Content Loading...
Content Loading...
Last Item Added: 0 Items
Content Loading...
» Close

Executive Management




Martin D. Madaus, Ph.D
Chairman of the Board, President, CEO

Dr. Madaus joined Millipore in January 2005 as President and Chief Executive Officer and became Chairman of the Board in March 2005.

Dr. Madaus came to Millipore from Roche Diagnostics Corporation where, as President and Chief Executive Officer (2000–2004), he was responsible for the North American Operations. Prior to that, he was Vice President of Business Development for Roche Molecular Diagnostics. Dr. Madaus joined Roche in 1998 when he was general manager of Boehringer Mannheim Canada in Montreal, Quebec, through the acquisition of Boehringer Mannheim by Roche. From 1989 to 1998, Dr. Madaus worked at Boehringer Mannheim in senior management, sales and marketing, and product management roles both in Germany and in the United States.

Dr. Madaus is a director of the Massachusetts High Technology Council, the New England Healthcare Institute, the Massachusetts Workforce Development Investment Board, and the YMCA of Greater Boston.

Dr. Madaus is a native of Hamburg, Germany (naturalized American citizen), and holds a D.V.M. and Ph.D. in veterinary medicine.

IR Contact

Contact for shareholders, potential investors and financial media.

Joshua S. Young
Director, Investor Relations
Tel: 978-715-1527
Joshua_Young@millipore.com

IR Services

Sign up for company alerts and download reports.

Safe Harbor Statement

The information on the Millipore investor relations website, as well as in future oral and written statements by management of Millipore Corporation that are forward-looking statements, are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements.

» More